POLR2A and neoplasm: Considering that RPB1 is a component of RNAPII, the major machinery of transcription, it may be even permitted to lose significant active RPB1 in the form of aggregates in tumor cell clones that otherwise tolerate the complete blockade of transcription by epirubicin.